Transactional Content Management

PRODUCTS

  • Batch and lot testing for release are critical steps in ensuring the quality and consistency of pharmaceutical tablets. Natoli Scientific provides comprehensive batch testing services that align with stringent industry standards and regulatory requirements. Each lot undergoes a rigorous analysis to verify that it meets predefined specifications for weight, tablet breaking force, thickness, diameter, and dissolution, among other critical quality attributes. The testing process is meticulously designed to screen for any variation that could impact the efficacy or safety of the final product.

    Utilizing state-of-the-art analytical equipment and methodologies, our experts ensure that each batch released by our clients is of the highest quality, providing end-users with the assurance that the medications they rely on are both safe and effective. This level of attention to detail fosters trust and reliability in pharmaceutical products processed through Natoli Scientific’s advanced batch and lot testing services.

  • Planning to launch a patient-centric decentralized clinical trial? Give your clinical trial patients an app that makes it easy to participate—from anywhere at any time.

  • Discover high-performance RF cables and adapters up to 40 GHz. These products feature customized options, rugged construction, and a three-year warranty, ensuring reliability for your testing needs.

  • The 362 Master series two-side labeler offers a wide range of equipment options with various print and label presence checks in combination with bad label return and product rejection.

  • Altasciences specializes in lead optimization studies, helping you identify the most promising drug candidates through precise, data-driven preclinical screening. Our expert scientists tailor each study to your unique needs, utilizing efficient non-GLP screening protocols to accelerate decision-making. With streamlined study designs, clear data visualization, and rapid turnaround times, we provide actionable insights to advance your drug discovery pipeline.

WHITE PAPERS AND CASE STUDIES

NEWS